We conducted a randomized controlled trial among Hispanics in Tampa, FL and Ponce, PR, to examine whether providing precision prevention information communicating MC1R genetic risk improves primary and secondary skin cancer prevention activities compared with providing generic prevention information. Here, MC1R is linked to skin neoplasm.